Pro: Is the Pulmonary Artery Catheter Dead?

Fluids and Organ Dysfunction: A Narrative Review of the Literature and Discussion of 5 Controversial Topics

Evidence-based clinical decision making is at the forefront of modern cardiothoracic anesthesia practice. Therefore, as a field, cardiac anesthesiologist should strive to ensure that the available evidence is of the highest possible quality. In this narrative review, 5 important topics that the authors believe require additional investigation in cardiothoracic anesthesia and critical care related to fluid therapy and organ dysfunction are outlined briefly. In particular, the authors believe that the areas of pulmonary artery catheter use, restrictive versus liberal transfusion strategies, cardiopulmonary bypass prime composition, colloid use in resuscitation and its effects on acute kidney injury, and management of acute kidney injury after cardiac surgery hold many unanswered questions and opportunities for continued improvement in the specialty of cardiac anesthesia. This article accompanies a presentation at the 46th Association of Cardiac Anesthesiologists Annual Meeting on October 22, 2017.

Current use of the pulmonary artery catheter

PURPOSE OF REVIEW

The pulmonary artery catheter is one of the most scrutinized monitors used in intensive care today. Pulmonary artery catheter use is declining due to limited demonstrated beneficial outcomes and the advancement of less invasive monitoring. This study discusses the current use of the pulmonary artery catheter and problems associated with its use including inaccuracy of measurements and data interpretation, inappropriately applied therapeutic interventions, inappropriate delays in applying interventions, and inappropriate patient selection.

RECENT FINDINGS

This overview presents current controversies surrounding the pulmonary artery catheter. It also discusses commonly used monitors and their lack of demonstrated benefits. In addition, data show that intensivists do not have sufficient knowledge to effectively use the pulmonary artery catheter. When utilized in a timely appropriate manner, pulmonary artery catheter monitoring may benefit a selected patient population.

SUMMARY

In summary, the pulmonary artery catheter monitor continues to be used for intensive care patients. To date, no single monitor is associated with an abundance of clear outcome benefits. There are some clinical data showing that the pulmonary artery catheter may still be useful when applied to the right patient population using appropriately timed therapies.

Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload

PURPOSE OF REVIEW

The purpose of this review is to provide an overview of concepts recently presented in the literature that impact our understanding of transfusion related acute lung injury (TRALI) and transfusion associated circulatory overload (TACO), and how to distinguish between the two disorders.

RECENT FINDINGS

An exceptionally clear review article by Brux and Sachs clarified the two-hit model of TRALI pathogenesis. The TRALI definition developed at the 2004 consensus conference helped demonstrate that TRALI is likely underreported. Brain natriuretic peptide can be useful in distinguishing cardiogenic from noncardiogenic pulmonary edema. Blood centers are implementing male predominant plasma programs to limit TRALI, and preliminary evidence suggests that this is a useful intervention.

SUMMARY

TACO and TRALI have emerged as important causes of posttransfusion morbidity and mortality. As understanding of their pathogenesis improves, incidence, risk factors, differences, and possible preventive interventions are becoming clearer. There is no sentinel feature that distinguishes TRALI from TACO. Developing a thorough clinical profile including presenting signs and symptoms, fluid status, cardiac status including measurement of brain natriuretic peptide, and leukocyte antibody testing is the best strategy currently available to distinguish the two disorders.